Elevated regulatory T cells in pediatric patients recovering from multisystem inflammatory syndrome (MIS-C) are

Isabela Silva-Avelar1, Bruna Danielly Santos-Silva1, Yingying Zheng1

  • 1Departamento de Pediatria, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.

Human Immunology
|July 5, 2025
PubMed

Insights

Children recovering from COVID-19 exhibit altered regulatory T cell (Treg) profiles, with Multisystem Inflammatory Syndrome in Children (MIS-C) patients showing higher Treg counts and a temporary immunosuppressive state. These immune changes normalize approximately one year post-infection.

Area of Science:

  • Immunology
  • Pediatric Infectious Diseases
  • Post-COVID Conditions

Background:

  • Multisystem Inflammatory Syndrome in Children (MIS-C) is a severe post-COVID-19 condition.
  • Regulatory T cells (Tregs) play a crucial role in modulating immune responses during inflammation.

Purpose of the Study:

  • To investigate the Treg cell profile in pediatric patients during recovery from COVID-19.
  • To compare Treg cell populations at two distinct convalescence time points (2-8 months and 10-15 months post-infection).

Main Methods:

  • Prospective cohort study involving COVID-19 (CV) and MIS-C (MV) convalescent groups, plus a control group.
  • Analysis of Treg phenotypes and cytokine profiles (IL-6, IL-8, IL-12, IL-1β, TNF-α, IL-10, TGF-β) using flow cytometry and ELISA.
  • Participants were unvaccinated children aged 2-18 years with confirmed SARS-CoV-2 infection.

Main Results:

  • COVID-19 and MIS-C groups initially showed reduced inflammatory cytokines (IL-1β, IL-8, IL-12, TNF-α), which normalized by the second visit.
  • MIS-C patients (MV1) exhibited higher Treg cell numbers, including CD45RA+ and CTLA-4+ subpopulations, compared to COVID-19 patients (CV1).
  • The Foxp3/CD45RA ratio was significantly higher in COVID-19 patients compared to controls and lower in MIS-C patients at the second visit.

Conclusions:

  • Pediatric COVID-19 recovery is associated with dynamic changes in Treg cell populations, linked to disease severity.
  • MIS-C patients experience a more pronounced temporary immunosuppressive state with elevated Treg counts, which gradually resolves over a year.
  • Treg cell profiling offers insights into immune recovery trajectories following COVID-19 and MIS-C in children.
Abstract